What is the recommended dosing and administration of linagliptin (a dipeptidyl peptidase-4 inhibitor) and dapagliflozin (a sodium-glucose cotransporter 2 inhibitor) for a patient with type 2 diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Take Linagliptin and Dapagliflozin

Take linagliptin 5 mg once daily at any time of day (with or without food) and dapagliflozin 10 mg once daily in the morning, preferably before the first meal of the day. 1, 2

Standard Dosing Regimen

Linagliptin:

  • Take 5 mg once daily at any time, regardless of meals 1, 3
  • No dose adjustment needed for any level of kidney function, making it unique among DPP-4 inhibitors 1, 4
  • Can be taken at the same time as dapagliflozin for convenience 5

Dapagliflozin:

  • Take 10 mg once daily, preferably in the morning 2, 6
  • Can be taken with or without food 2
  • This is a fixed dose for cardiovascular and kidney protection—no titration needed 2

Important Timing Considerations

  • Both medications can be taken together at the same time each day for simplicity 5, 7
  • If you prefer morning dosing for both, take them with your first meal or shortly before 2
  • Consistency in timing helps maintain steady drug levels, though missing the exact time by a few hours is not critical 3

Critical Safety Instructions: When to STOP Taking These Medications

You must temporarily stop dapagliflozin during any acute illness, especially if you have: 2

  • Fever, vomiting, or diarrhea
  • Reduced ability to eat or drink normally
  • Any illness requiring hospitalization
  • Planned surgery (stop at least 3 days before) 2

Continue linagliptin during illness, but stop dapagliflozin and contact your healthcare provider immediately. 2

Monitoring Your Kidney Function

  • Your kidney function (eGFR) should be checked before starting and within 1-2 weeks after initiation 2
  • Expect a small, temporary drop in kidney function (3-5 mL/min/1.73 m²) in the first 1-4 weeks—this is normal and actually indicates the medication is working 2
  • If your eGFR is 45 mL/min/1.73 m² or higher, no dose changes are needed 1, 2
  • If your eGFR falls below 45 mL/min/1.73 m², dapagliflozin becomes less effective for blood sugar control but should still be continued for heart and kidney protection 2

Managing Other Diabetes Medications

If you take insulin or sulfonylureas (like glyburide, glipizide, glimepiride): 1

  • Your doctor should reduce these doses when starting dapagliflozin to prevent low blood sugar
  • Insulin doses typically need a 20-35% reduction 1
  • Sulfonylurea doses may need a 50% reduction 1

If you take metformin: 7

  • Continue your current dose—no adjustment needed in most cases
  • The combination of metformin, linagliptin, and dapagliflozin has a low risk of causing low blood sugar 2

Common Side Effects to Watch For

Genital yeast infections (6% of patients on dapagliflozin): 2

  • More common in women
  • Practice good daily hygiene to reduce risk
  • Report symptoms promptly for treatment

Urinary tract infections: 2

  • Drink adequate fluids throughout the day
  • Report burning with urination or fever immediately

Increased urination: 6

  • This is expected with dapagliflozin and indicates the medication is working
  • Typically improves after the first few weeks
  • Stay well-hydrated

Dizziness or lightheadedness when standing: 2

  • Dapagliflozin can cause mild dehydration, especially in the first weeks
  • Rise slowly from sitting or lying positions
  • Drink adequate fluids (8-10 glasses of water daily unless otherwise instructed)
  • If you take diuretics (water pills), your doctor may need to reduce the dose 2

Rare but Serious Warning Signs—Seek Immediate Medical Attention

Diabetic ketoacidosis (can occur even with normal blood sugar): 2

  • Nausea, vomiting, or abdominal pain
  • Unusual fatigue or confusion
  • Difficulty breathing
  • Fruity-smelling breath

Severe genital or perineal infection (Fournier's gangrene—extremely rare): 2

  • Severe pain, tenderness, redness, or swelling in the genital or perineal area
  • Fever above 100.4°F (38°C)

Practical Tips for Success

  • Set a daily alarm on your phone to take both medications at the same time 3
  • Keep a 7-day pill organizer to track whether you've taken your doses 3
  • If you miss a dose, take it as soon as you remember on the same day; if it's almost time for the next dose, skip the missed dose—never double up 3
  • Carry a medical alert card or wear a bracelet indicating you take SGLT2 inhibitors, especially important for emergency situations 2
  • Keep a list of "sick day rules" on your refrigerator: stop dapagliflozin during illness, maintain hydration, check ketones if you feel unwell 2

Common Pitfalls to Avoid

  • Do not stop dapagliflozin just because your kidney function drops below 45 mL/min/1.73 m²—the heart and kidney protective benefits continue even when blood sugar-lowering effects diminish 2
  • Do not reduce fluid intake to avoid frequent urination—this increases your risk of dehydration and kidney problems 2
  • Do not continue dapagliflozin during illness—this is the most common cause of preventable ketoacidosis 2
  • Do not assume normal blood sugar means you're safe from ketoacidosis—SGLT2 inhibitors can cause ketoacidosis even with blood sugars in the normal range 2

Related Questions

Can Trajenta Duo (Linagliptin and Metformin) 2.5/500 mg be given twice daily to an adult patient with type 2 diabetes?
What is the recommended dosage of linagliptina (diabetes medication) for a patient with type 2 diabetes?
What are the adverse effects of Tradjenta (linagliptin)?
Can Trajenta (linagliptin), Forxiga (dapagliflozin), and Levemir (insulin detemir) be combined in the management of type 2 diabetes?
Is it recommended to use Farxiga (dapagliflozin) and Tradjenta (linagliptin) together for a patient with type 2 diabetes and potential Zika exposure?
Would a patient developing Subacute Sclerosing Panencephalitis (SSPE) after having measles likely present with retinitis one year post-measles infection?
What are the next steps for a patient with a history of breast cancer who has undergone a failed sentinel lymph node (SLN) biopsy?
What is the diagnosis and treatment for a patient with symptoms of urinary urgency and frequency, brown and turbid urine, positive nitrite, 2+ leukocyte esterase, 5+ blood, 100 mg/dL protein, elevated ammonia level of 122, and a white blood cell (WBC) count of 15,000?
What is the clinical significance and management of elevated fecal calprotectin in a patient with suspected inflammatory bowel disease (IBD)?
What is the current evidence on the management of Traumatic Brain Injury (TBI) using multimodal neuromonitoring, including intracranial pressure (ICP) monitoring and medication, in adult patients?
What is the recommended treatment approach for a patient with hypertension in an outpatient setting, considering comorbidities such as diabetes and kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.